Quarterly Report

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark one)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2010

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number 1-434

 

 

LOGO

THE PROCTER & GAMBLE COMPANY

(Exact name of registrant as specified in its charter)

 

 

 

Ohio   31-0411980
(State of Incorporation)   (I.R.S. Employer Identification Number)

 

One Procter & Gamble Plaza, Cincinnati, Ohio   45202
(Address of principal executive offices)   (Zip Code)

(513) 983-1100

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  þ    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  þ    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Large accelerated filer  þ                    Accelerated filer  ¨                    Non-accelerated filer  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  þ

There were 2,799,193,095 shares of Common Stock outstanding as of September 30, 2010.

 

 

 


 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements.

The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the “Company”, “we” or “our”) for the three months ended September 30, 2010 and 2009, the Consolidated Balance Sheets as of September 30, 2010 and June 30, 2010, and the Consolidated Statements of Cash Flows for the three months ended September 30, 2010 and 2009 follow. In the opinion of management, these unaudited Consolidated Financial Statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EARNINGS

 

     Three Months Ended
September 30
 

Amounts in millions except per share amounts

   2010     2009  

Net Sales

   $ 20,122      $ 19,807   

Cost of products sold

     9,689        9,398   

Selling, general and administrative expense

     5,932        5,961   
                

Operating Income

     4,501        4,448   

Interest expense

     208        287   

Other non-operating income/(expense), net

     (11     23   
                

Earnings from Continuing Operations Before Income Taxes

     4,282        4,184   

Income taxes on continuing operations

     1,201        1,157   
                

Net Earnings from Continuing Operations

     3,081        3,027   

Net Earnings from Discontinued Operations

     0        280   
                

Net Earnings

   $ 3,081      $ 3,307   
                

Per Common Share

    

Basic net earnings from continuing operations

   $ 1.07      $ 1.02   

Basic net earnings from discontinued operations

     —          0.09   
                

Basic net earnings

     1.07        1.11   

Diluted net earnings from continuing operations

     1.02        0.97   

Diluted net earnings from discontinued operations

     —          0.09   
                

Diluted net earnings

     1.02        1.06   

Dividends

   $ 0.48      $ 0.44   

Diluted Weighted Average Common Shares Outstanding

     3,025.6        3,109.6   

See accompanying Notes to Consolidated Financial Statements

 

- 2 -


 

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

Amounts in millions

                 September 30
2010
    June 30
2010
 

ASSETS

          

CURRENT ASSETS

          

Cash and cash equivalents

         $ 2,603      $ 2,879   

Accounts receivable

           6,082        5,335   

Inventories

          

Materials and supplies

           1,959        1,692   

Work in process

           683        604   

Finished goods

           4,635        4,088   
                      

Total inventories

           7,277        6,384   

Deferred income taxes

           968        990   

Prepaid expenses and other current assets

           3,566        3,194   
                      

TOTAL CURRENT ASSETS

           20,496        18,782   

PROPERTY, PLANT AND EQUIPMENT

          

Buildings

           7,259        6,868   

Machinery and equipment

           30,522        29,294   

Land

           892        850   
                      

Total property, plant and equipment

           38,673        37,012   

Accumulated depreciation

           (18,796     (17,768
                      

NET PROPERTY, PLANT AND EQUIPMENT

           19,877        19,244   

GOODWILL AND OTHER INTANGIBLE ASSETS

          

Goodwill

           56,171        54,012   

Trademarks and other intangible assets, net

           32,369        31,636   
                      

NET GOODWILL AND OTHER INTANGIBLE ASSETS

           88,540        85,648   

OTHER NONCURRENT ASSETS

           4,779        4,498   
                      

TOTAL ASSETS

         $ 133,692      $ 128,172   
                      

LIABILITIES AND SHAREHOLDERS’ EQUITY

          

CURRENT LIABILITIES

          

Accounts payable

         $ 6,716      $ 7,251   

Accrued and other liabilities

           9,412        8,559   

Debt due within one year

           11,512        8,472   
                      

TOTAL CURRENT LIABILITIES

           27,640        24,282   

LONG-TERM DEBT

           21,464        21,360   

DEFERRED INCOME TAXES

           10,709        10,902   

OTHER NONCURRENT LIABILITIES

           10,678        10,189   
                      

TOTAL LIABILITIES

           70,491        66,733   

SHAREHOLDERS’ EQUITY

          

Preferred stock

           1,260        1,277   

Common stock – shares issued –

     30-Sep         4,007.7         4,008     
     30-Jun         4,007.6           4,008   

Additional paid-in capital

           61,839        61,697   

Reserve for ESOP debt retirement

           (1,353     (1,350

Accumulated other comprehensive income (loss)

           (5,007     (7,822

Treasury stock

           (64,174     (61,309

Retained earnings

           66,282        64,614   

Noncontrolling interest

           346        324   
                      

TOTAL SHAREHOLDERS’ EQUITY

           63,201        61,439   
                      

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

         $ 133,692      $ 128,172   
                      

See accompanying Notes to Consolidated Financial Statements

 

- 3 -


 

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

     Three Months Ended
September 30
 

Amounts in millions

   2010     2009  

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

   $ 2,879      $ 4,781   

OPERATING ACTIVITIES

    

Net earnings

     3,081        3,307   

Depreciation and amortization

     689        771   

Share-based compensation expense

     87        99   

Deferred income taxes

     48        (29

(Gain)/loss on sale of businesses

     2        (199

Changes in:

    

Accounts receivable

     (434     (513

Inventories

     (604     (96

Accounts payable, accrued and other liabilities

     (303     818   

Other operating assets and liabilities

     19        398   

Other

     (133     (1
                

TOTAL OPERATING ACTIVITIES

     2,452        4,555   
                

INVESTING ACTIVITIES

    

Capital expenditures

     (519     (552

Proceeds from asset sales

     14        209   

Acquisitions, net of cash acquired

     (398     (19

Change in investments

     (25     (16
                

TOTAL INVESTING ACTIVITIES

     (928     (378
                

FINANCING ACTIVITIES

    

Dividends to shareholders

     (1,422     (1,336

Change in short-term debt

     2,412        1,914   

Additions to long-term debt

     1        1,496   

Reductions of long-term debt

     (18     (4,986

Treasury stock purchases

     (3,010     (8

Impact of stock options and other

     136        117   
                

TOTAL FINANCING ACTIVITIES

     (1,901     (2,803
                

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

     101        139   

CHANGE IN CASH AND CASH EQUIVALENTS

     (276     1,513   
                

CASH AND CASH EQUIVALENTS, END OF PERIOD

   $ 2,603      $ 6,294   
                

See accompanying Notes to Consolidated Financial Statements

 

- 4 -


 

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

1. These statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2010. The results of operations for the three-month period ended September 30, 2010 are not necessarily indicative of annual results.

 

2. Comprehensive Income - Total comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges, net unrealized gains and losses on investment securities and defined benefit and other retiree benefit plan activities. Total comprehensive income for the three months ended September 30, 2010 and 2009 was $5,896 million and $4,702 million, respectively.

 

3. Segment Information - Following is a summary of segment results. As discussed in Note 10, a certain divested business is presented as discontinued operations and is excluded from segment results for all periods presented.

Following is a summary of segment results.

 

            Three Months Ended September 30  

Amounts in millions

          Net Sales     Earnings  from
Continuing
Operations
Before
Income Taxes
    Net Earnings
from
Continuing
Operations
 

Beauty and Grooming GBU

         

Beauty

     2010       $ 4,929      $ 1,081      $ 829   
     2009         4,921        1,027        777   
                                 

Grooming

     2010         1,898        524        398   
     2009         1,858        489        351   

Health and Well-Being GBU

         

Health Care

     2010         2,984        741        495   
     2009         2,979        830        550   
                                 

Snacks and Pet Care

     2010         709        77        54   
     2009         755        113        74   

Household Care GBU

         

Fabric Care and Home Care

     2010         6,297        1,417        937   
     2009         6,130        1,510        1,009   
                                 

Baby Care and Family Care

     2010         3,652        749        470   
     2009         3,589        885        557   

Corporate

     2010         (347     (307     (102
     2009         (425     (670     (291
                                 

Total

     2010         20,122        4,282        3,081   
     2009         19,807        4,184        3,027   
                                 

 

- 5 -


 

4. Goodwill and Other Intangible Assets - Goodwill as of September 30, 2010 is allocated by reportable segment and global business unit as follows (amounts in millions):

 

     Three Months  Ended
September 30, 2010
 

BEAUTY & GROOMING GBU

  

Beauty, beginning of year

   $ 17,575   

Acquisitions and divestitures

     —     

Translation and other

     898   
        

Goodwill, September 30, 2010

     18,473   

Grooming, beginning of year

     20,384   

Acquisitions and divestitures

     (2

Translation and other

     738   
        

Goodwill, September 30, 2010

     21,120   

HEALTH & WELL-BEING GBU

  

Health Care, beginning of year

     7,859   

Acquisitions and divestitures

     —     

Translation and other

     196   
        

Goodwill, September 30, 2010

     8,055   

Snacks and Pet Care, beginning of year

     2,203   

Acquisitions and divestitures

     14   

Translation and other

     15   
        

Goodwill, September 30, 2010

     2,232   

HOUSEHOLD CARE GBU

  

Fabric Care and Home Care, beginning of year

     4,248   

Acquisitions and divestitures

     78   

Translation and other

     150   
        

Goodwill, September 30, 2010

     4,476   

Baby Care and Family Care, beginning of year

     1,445   

Acquisitions and divestitures

     —     

Translation and other

     72   
        

Goodwill, September 30, 2010

     1,517   

CORPORATE

  

Corporate, beginning of year

     298   

Acquisitions and divestitures

     —     

Translation and other

     —     
        

Goodwill, September 30, 2010

     298   

GOODWILL, beginning of year

     54,012   

Acquisitions and divestitures

     90   

Translation and other

     2,069   
        

Goodwill, September 30, 2010

   $ 56,171   
        

The increase in goodwill from June 30, 2010 is primarily due to currency translation across all GBUs and the acquisition of Ambi Pur.

 

- 6 -


 

Identifiable intangible assets as of September 30, 2010 are comprised of (amounts in millions):

 

     Gross Carrying
Amount
     Accumulated
Amortization
 

Amortizable intangible assets with determinable lives

   $ 8,901       $ 3,779   

Intangible assets with indefinite lives

     27,247         —     
                 

Total identifiable intangible assets

   $ 36,148       $ 3,779   
                 

Amortizable intangible assets consist principally of brands, patents, technology and customer relationships. The non-amortizable intangible assets consist primarily of brands.

The amortization of intangible assets for the three months ended September 30, 2010 and 2009 was $140 million and $145 million, respectively.

 

5. Pursuant to applicable accounting guidance for share-based payments, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards.

Total share-based compensation for the three months ended September 30, 2010 and 2009 are summarized in the following table (amounts in millions):

 

     Three Months Ended
September 30
 
     2010      2009  

Share-Based Compensation

     

Stock options

   $ 68       $ 93   

Other share-based awards

     19         6   
                 

Total share-based compensation

   $ 87       $ 99   
                 

Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience.

 

6. Postretirement Benefits - The Company offers various postretirement benefits to its employees.

The components of net periodic benefit cost for defined benefit plans are as follows:

 

     Pension Benefits     Other Retiree Benefits  
     Three Months Ended
September 30
    Three Months Ended
September 30
 

Amounts in millions

   2010     2009     2010     2009  

Service cost

   $ 62      $ 55      $ 35      $ 26   

Interest cost

     140        147        65        63   

Expected return on plan assets

     (119     (111     (108     (107

Amortization of deferred amounts

     4        4        (5     (5

Recognized net actuarial loss

     37        23        24        4   
                                

Gross benefit cost (credit)

     124        118        11        (19

Dividends on ESOP preferred stock

     —          —          (20     (28
                                

Net periodic benefit cost (credit)

   $ 124      $ 118      $ (9   $ (47
                                

 

- 7 -


 

For the year ending June 30, 2011, the expected return on plan assets is 7.0% and 9.2% for defined benefit and other retiree benefit plans, respectively.

 

7. Risk Management Activities and Fair Value Measurements

As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices.

For details on the Company’s risk management activities, refer to the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2010.

Fair Value Hierarchy

For a discussion of the Company’s fair value measurement policies under the fair value hierarchy, refer to the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2010.

The Company has not changed its valuation techniques in measuring the fair value of any financial assets and liabilities during the period.

The following table sets forth the Company’s financial assets and liabilities as of September 30 and June 30, 2010 that are measured at fair value on a recurring basis during the period, segregated by level within the fair value hierarchy:

 

     Level 1      Level 2      Level 3      Total  

Amounts in millions

   September 30,
2010
     June 30,
2010
     September 30,
2010
     June 30,
2010
     September 30,
2010
     June 30,
2010
     September 30,
2010
     June 30,
2010
 

Assets at fair value:

                       

Investment securities

   $ 21       $ 12       $ —         $ —         $ 23       $ 45       $ 44       $ 57   

Derivatives relating to:

                       

Other foreign currency instruments (1)

     —           —           302         81         —           —           302         81   

Interest rates

     —           —           253         191         —           —           253         191   

Net investment hedges

     —           —           —           14         —           —           —           14   

Commodities

     —           —           6         10         —           —           6         10   
                                                                       

Total assets at fair value (2)

     21         12         561         296         23         45         605         353   
                                                                       

Liabilities at fair value:

                       

Derivatives relating to:

                       

Foreign currency hedges

     —           —           233         177         —           —           233         177   

Other foreign currency instruments (1)

     —           —           13         175         —           —           13         175   

Net investment hedges

     —           —           88         23         —           —           88         23   

Commodities

     —           —           1         —           —           —           1         —     
                                                                       

Total liabilities at fair value (3)

     —           —           335         375         —           —           335         375   
                                                                       

 

  (1) Other foreign currency instruments are comprised of foreign currency financial instruments that do not qualify as hedges.
  (2) Investment securities are presented in other noncurrent assets and all derivative assets are presented in prepaid expenses and other current assets or other noncurrent assets.
  (3) All liabilities are presented in accrued and other liabilities or other noncurrent liabilities.

The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There was no significant activity within the Level 3 assets and liabilities during the periods presented.

There were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis during the periods presented.

 

- 8 -


 

Certain of the Company’s financial instruments used in hedging transactions are governed by industry standard netting agreements with counterparties. If the Company’s credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangement. The aggregate fair value of the instruments covered by these contractual features that are in a net liability position as of September 30, 2010 was $177 million. The Company has never been required to post any collateral as a result of these contractual features.

Fair Values of Other Financial Instruments

Other financial instruments, including cash equivalents, other investments and short-term debt, are recorded at cost, which approximates fair value. The fair value of the long-term debt was $23,707 million and $23,072 million at September 30 and June 30, 2010, respectively.

Disclosures about Derivative Instruments

The notional amounts and fair values of qualifying and non-qualifying financial instruments used in hedging transactions as of September 30 and June 30, 2010 are as follows:

 

    Notional Amount     Fair Value Asset (Liability)  

Amounts in Millions

  September 30, 2010     June 30, 2010     September 30, 2010     June 30, 2010  

Derivatives in Cash Flow Hedging Relationships

       

Interest rate contracts

  $ —        $ —        $ —        $ —     

Foreign currency contracts

    690        690        (233     (177

Commodity contracts

    30        43        4        10   
                               

Total

    720        733        (229     (167
                               

Derivatives in Fair Value Hedging Relationships

       
                               

Interest rate contracts

    8,344        7,942        253        191   
                               

Derivatives in Net Investment Hedging Relationships

       
                               

Net investment hedges

    1,492        1,586        (88     (9
                               

Derivatives Not Designated as Hedging Instruments

       

Foreign currency contracts

    11,582        11,845        289        (94

Commodity contracts

    44        19        1        —     
                               

Total

    11,626        11,864        290        (94
                               

The total notional amount of contracts outstanding at the end of the period is indicative of the level of the Company’s derivative activity during the period.

 

- 9 -


 

     Amount of Gain (Loss) Recognized in
Accumulated OCI on Derivatives (Effective Portion)
 

Amounts in Millions

   September 30, 2010     June 30, 2010  

Derivatives in Cash Flow Hedging Relationships

    

Interest rate contracts

   $ 18      $ 19   

Foreign currency contracts

     21        23   

Commodity contracts

     4        11   
                

Total

     43        53   
                

Derivatives in Net Investment Hedging Relationships

    
                

Net investment hedges

     (57     (8
                

During the next 12 months, the amount of the September 30, 2010 accumulated other comprehensive income (OCI) balance that will be reclassified to earnings is expected to be immaterial.

The amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three months ended September 30, 2010 and 2009 are as follows:

 

     Amount of Gain (Loss) Reclassified
from Accumulated OCI into  Income (1)
 
     Three Months Ended September 30  

Amounts in Millions

   2010     2009  

Derivatives in Cash Flow Hedging Relationships

    

Interest rate contracts

   $ 2      $ (7

Foreign currency contracts

     (49     (51

Commodity contracts

     14        (61
                

Total

     (33     (119
                
     Amount of Gain (Loss) Recognized in Income  
     Three Months Ended September 30  

Amounts in Millions

   2010     2009  

Derivatives in Fair Value Hedging Relationships (2)

    

Interest rate contracts

     62        52   

Debt

     (63     (57
                

Total

     (1     (5
                

Derivatives in Net Investment Hedging Relationships (2)

    
                

Net investment hedges

     —          —     
                

Derivatives Not Designated as Hedging Instruments (3)

    

Foreign currency contracts

     736        260   

Commodity contracts

     2        —     
                

Total

     738        260   
                

 

  (1) The gain or loss on the effective portion of cash flow hedging relationships is reclassified from accumulated OCI into net income in the same period during which the related item affects earnings. Such amounts are included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and interest expense and commodity contracts in cost of products sold.

 

- 10 -


(2) The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in interest expense.
(3) The gain or loss on contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings as follows: foreign currency contracts in selling, general and administrative expense and commodity contracts in cost of products sold.

 

8. New Accounting Pronouncements and Policies

No new accounting pronouncement issued or effective during the fiscal year has had or is expected to have a material impact on the Consolidated Financial Statements.

 

9. Commitments and Contingencies

Litigation

We are subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as governmental regulations, antitrust and trade regulations, product liability, patent and trademark matters, income taxes and other actions.

As previously disclosed, the Company is subject to a variety of investigations into potential competition law violations in Europe by the European Commission and national authorities from a number of countries, as detailed in Part 2, Item 1, Legal Proceedings of this 10-Q. These matters involve a number of consumer products companies and/or retail customers. The Company’s policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines.

In response to the actions of the European Commission and national authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company has identified violations in certain European countries and appropriate actions were taken.

Several countries in Europe have issued separate complaints pursuant to their investigations alleging that the Company, along with several other companies, engaged in violations of competition laws in those countries. The Company either has, or will have, the opportunity to respond to these complaints. As a result of our initial and on-going analyses of these complaints, the Company has reserves totaling $275 million as of September 30, 2010 for potential fines for competition law violations. The ultimate resolution of these matters could result in fines or costs significantly in excess of the amounts reserved.

The remaining matters involving the European Commission and various other countries are in various stages of the investigatory process. It is still too early for us to reasonably estimate the total amount of fines to which the Company will be subject as a result of these competition law issues. The ultimate resolution of these matters will likely result in fines or other costs that could materially impact our income statement and cash flows in the period in which they are accrued and paid, respectively. In other industries, these fines have amounted to hundreds of millions of dollars. We will continue to monitor developments for all of these investigations and will record additional charges as appropriate.

With respect to other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.

We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal

 

- 11 -


practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will have a material adverse effect on our financial position, results of operations or cash flows.

Income Tax Uncertainties

The Company is present in over 150 taxable jurisdictions and, at any point in time, has 50 – 60 audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statute of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 1997 and forward. We are generally not able to reliably estimate the ultimate settlement amounts or timing until the close of the audit. At this time, we are not able to make a reasonable estimate of the range of impact on the balance of uncertain tax positions or the impact on the effective tax rate related to these items.

Additional information on the Commitments and Contingencies of the Company can be found in Note 10, Commitments and Contingencies, which appears in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2010.

 

10. Discontinued Operations

In October 2009, the Company completed the divestiture of our global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott) for $2.8 billion of cash, net of assumed and transferred liabilities. Under the terms of the agreement, Warner Chilcott acquired our portfolio of branded pharmaceutical products, our prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. In addition, the majority of the employees working on the pharmaceuticals business were transferred to Warner Chilcott. The Company recorded an after-tax gain on the transaction of $1,464 million in the quarter ended December 31, 2009. In accordance with the applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, have been excluded from continuing operations for all periods presented.

Following is selected financial information included in net earnings from discontinued operations for the pharmaceuticals business:

 

     Three months ended September 30  

Amounts in millions

       2010              2009      

Net sales

   $ —         $ 555   
                 

Earnings from discontinued operation

     —           430   

Income tax expense

     —           (150
                 

Net earnings from discontinued operations

     —           280   
                 

 

- 12 -


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The purpose of this discussion is to provide an understanding of P&G’s financial results and condition by focusing on changes in certain key measures from year to year. Management’s Discussion and Analysis (MD&A) is organized in the following sections:

 

   

Overview

 

   

Summary of Results

 

   

Forward-Looking Statements

 

   

Results of Operations – Three Months Ended September 30, 2010

 

   

Business Segment Discussion – Three Months Ended September 30, 2010

 

   

Financial Condition

 

   

Reconciliation of Non-GAAP Measures

Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net outside sales and after-tax profit. We also refer to organic sales growth, free cash flow and free cash flow productivity. These financial measures are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of such information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates.

OVERVIEW

P&G’s business is focused on providing branded consumer goods products. Our purpose is to provide products and services of superior quality and value that improve the lives of the world’s consumers, now and for generations to come. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper.

Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores, drug stores and “high frequency stores,” the neighborhood stores which serve many consumers in developing markets. We continue to expand our presence in other channels including department stores, perfumeries, pharmacies, salons and e-commerce.

We compete in multiple product categories and have three global business units (GBUs): Beauty and Grooming; Health and Well-Being; and Household Care. Under U.S. GAAP, the business units comprising the GBUs are aggregated into six reportable segments: Beauty; Grooming; Health Care; Snacks and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care.

We have on-the-ground operations in approximately 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along five geographic units: North America, Western Europe, Central & Eastern Europe/Middle East/Africa (CEEMEA), Latin America and Asia, which is comprised of Japan, Greater China and ASEAN/Australia/India/Korea (AAIK). Throughout MD&A, we reference business results in developing markets, which we define as the aggregate of CEEMEA, Latin America, AAIK and Greater China, and developed markets, which are comprised of North America, Western Europe and Japan.

On October 30, 2009, we sold our global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott) for $2.8 billion. Under the terms of the agreement, Warner Chilcott acquired our portfolio of branded

 

- 13 -


pharmaceuticals products, prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. The pharmaceuticals business had historically been part of the Health Care reportable segment. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, are excluded from continuing operations and from segment results.

The table below provides more information about the components of our GBU structure.

 

GBU

  

Reportable
Segment

  

Categories

  

Billion-Dollar Brands

Beauty and Grooming

   Beauty    Cosmetics, Female Antiperspirant and Deodorant, Female Personal Cleansing, Female Shave Care, Hair Care, Hair Color, Hair Styling, Pharmacy Channel, Prestige Products, Salon Professional, Skin Care    Head & Shoulders, Olay, Pantene, Wella
   Grooming    Beauty Electronics, Home Small Appliances, Male Blades and Razors, Male Personal Care    Braun, Fusion, Gillette, Mach3

Health and Well-Being

   Health Care    Feminine Care, Gastrointestinal, Incontinence, Rapid Diagnostics, Respiratory, Toothbrush, Toothpaste, Water Filtration, Other Oral Care    Always, Crest, Oral-B
   Snacks and Pet Care    Pet Care, Snacks    Iams, Pringles

Household Care

   Fabric Care and Home Care    Additives, Air Care, Batteries, Dish Care, Fabric Enhancers, Laundry, Surface Care    Ace, Ariel, Dawn, Downy, Duracell, Gain, Tide
   Baby Care and Family Care    Baby Wipes, Diapers, Paper Towels, Tissues, Toilet Paper    Bounty, Charmin, Pampers

The following table provides the percentage of net sales and net earnings from continuing operations by reportable business segment for the three months ended September 30, 2010 (excludes net sales and net earnings in Corporate):

 

     Net Sales     Net Earnings  

Beauty and Grooming GBU

    

Beauty

     24     26

Grooming

     9     12

Health and Well-Being GBU

    

Health Care

     15     16

Snacks and Pet Care

     3     2

Household Care GBU

    

Fabric Care and Home Care

     31     29

Baby Care and Family Care

     18     15

Total

     100     100

SUMMARY OF RESULTS

Following are highlights of results for the three months ended September 30, 2010:

 

   

Net sales increased 2% to $20.1 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, were up 4%.

 

   

Unit volume grew 8%, led by double-digit growth in the Fabric Care and Home Care and Baby Care and Family Care segments.

 

- 14 -


 

   

Net earnings from continuing operations were $3.1 billion, an increase of 2% versus the prior year period mainly due to net sales growth.

 

   

Net earnings declined 7% to $3.1 billion due to the lost contribution from the discontinued pharmaceuticals business.

 

   

Diluted net earnings per share from continuing operations increased 5% to $1.02. Earnings per share growth exceeded net earnings growth due to the impact of share repurchase activity.

 

   

Diluted net earnings per share decreased 4% versus the prior year period to $1.02 as the loss of contribution from discontinued operations was only partially offset by increased earnings from continuing operations.

 

   

Operating cash flow decreased $2.1 billion versus the prior year period to $2.5 billion mainly due to an increase in working capital. Free cash flow, which is operating cash flow less capital expenditures, was $1.9 billion. Free cash flow productivity, which is the ratio of free cash flow to net earnings, was 63%.

FORWARD-LOOKING STATEMENTS

We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are “forward-looking statements,” and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain and investors must recognize that events could be significantly different from our expectations. For more information on risks that could impact our results, refer to Item 1A Risk Factors in our most recent 10-K filing.

Ability to Achieve Business Plans: We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations and on the continued positive reputations of our brands. This means we must be able to obtain patents and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives, trade terms and product initiatives. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of ongoing acquisition and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Our success will also depend on our ability to maintain key information technology systems.

Cost Pressures: Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in certain countries, such as Venezuela, China and India. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce optimization. Successfully managing these changes, including identifying, developing and retaining key employees, is critical to our success.

 

- 15 -


 

Global Economic Conditions: Economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to terrorist and other hostile activities.

Regulatory Environment: Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Our ability to manage regulatory, tax and legal matters (including product liability, patent, intellectual property, competition law matters and tax policy) and to resolve pending legal matters within current estimates may impact our results.

RESULTS OF OPERATIONS – Three Months Ended September 30, 2010

The following discussion provides a review of results for the three months ended September 30, 2010 versus the three months ended September 30, 2009.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Consolidated Earnings Information

 

     Three Months Ended September 30  
     2010     2009     % CHG  

NET SALES

   $ 20,122      $ 19,807        2

COST OF PRODUCTS SOLD

     9,689        9,398        3
                        

GROSS MARGIN

     10,433        10,409        0

SELLING GENERAL & ADMINISTRATIVE EXPENSE

     5,932        5,961        0
                        

OPERATING INCOME

     4,501        4,448        1

TOTAL INTEREST EXPENSE

     208        287     

OTHER NON-OPERATING INCOME/(EXPENSE), NET

     (11     23     
                        

EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

     4,282        4,184        2

INCOME TAXES

     1,201        1,157     
                        

NET EARNINGS FROM CONTINUING OPERATIONS

     3,081        3,027        2

NET EARNINGS FROM DISCONTINUED OPERATIONS

     0        280     
                  

NET EARNINGS

     3,081        3,307        (7 )% 
                        

EFFECTIVE TAX RATE FROM CONTINUING OPERATIONS

     28.0     27.7  

PER COMMON SHARE:

      

BASIC NET EARNINGS – CONTINUING OPERATIONS

   $ 1.07      $ 1.02     

BASIC NET EARNINGS – DISCONTINUED OPERATIONS

   $ —        $ 0.09     
                  

BASIC NET EARNINGS

   $ 1.07      $ 1.11     

DILUTED NET EARNINGS – CONTINUING OPERATIONS

   $ 1.02      $ 0.97        5

DILUTED NET EARNINGS – DISCONTINUED OPERATIONS

   $ —        $ 0.09     
                        

DILUTED NET EARNINGS

   $ 1.02      $ 1.06        (4 )% 

DIVIDENDS

   $ 0.4818      $ 0.44        9.5

AVERAGE DILUTED SHARES OUTSTANDING

     3,025.6        3,109.6     

COMPARISONS AS A % OF NET SALES

               Basis Pt
Chg
 

GROSS MARGIN

     51.9     52.6     (70

SELLING, GENERAL & ADMINISTRATIVE EXPENSE

     29.5     30.1     (60

OPERATING MARGIN

     22.4     22.5     (10

EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

     21.3     21.1     20   

NET EARNINGS FROM CONTINUING OPERATIONS

     15.3     15.3     0   

 

- 16 -


 

Net sales increased 2% to $20.1 billion for the July - September quarter on an 8% increase in unit volume. Volume growth was broad based with growth in all geographic regions, led by double-digit growth in developing regions. Five of the six business segments contributed to volume growth, led by double-digit growth in the Fabric Care and Home Care and the Baby Care and Family Care segments. Volume in the Beauty, Grooming and Health Care segments was up mid-single digits, while volume in the Snacks and Pet Care segment declined low single digits. Organic volume, which excludes acquisitions and divestitures, increased 7%. Price reductions lowered net sales by 1% mainly due to pricing adjustments executed in previous periods, partially offset by price increases taken in developing regions to offset currency devaluations. Negative mix reduced net sales by 2% due mainly to disproportionate growth in developing regions and mid-tier value products, both of which have lower than Company average selling prices. Unfavorable foreign exchange lowered net sales by 3% as key foreign currencies weakened versus the U.S. dollar. Organic sales growth was 4% driven by unit volume growth, partially offset by the impact of price reductions and unfavorable mix.

 

     Net Sales Change Drivers 2010 vs. 2009 (Three Months Ended Sep. 30)  
     Volume with
Acquisitions &
Divestitures
    Volume excluding
Acquisitions &
Divestitures
    Foreign
Exchange
    Price     Mix/
Other
    Net Sales
Growth
 

Beauty and Grooming GBU

            

Beauty

     4     4     -2     0     -2     0

Grooming

     5     5     -4     1     0     2

Health and Well-Being GBU

            

Health Care

     6     6     -4     -2     0     0

Snacks and Pet Care

     -1     -4     -1     -2     -2     -6

Household Care GBU

            

Fabric Care and Home Care

     10     9     -3     -2     -2     3

Baby Care and Family Care

     10     10     -3     -2     -3     2
                                                

Total Company

     8     7     -3     -1     -2     2
                                                

Sales percentage changes are approximations based on quantitative formulas that are consistently applied.

Gross margin contracted 70 basis points to 51.9% of net sales in the first fiscal quarter. The reduction in gross margin was driven mainly by higher commodity and energy costs and unfavorable product mix, partially offset by the impact of volume scale leverage and manufacturing cost savings.

Total selling, general and administrative expenses (SG&A) were in line with the prior year period at $5.9 billion as higher marketing spending was offset by reduced overhead spending and the impact of higher base period foreign currency exchange costs primarily related to our operations in Venezuela. In the prior year period, foreign currency exchange costs related to our operations in Venezuela were approximately $320 million versus approximately $10 million in the current period. These costs included losses incurred to swap bolivars for U.S. dollars in the parallel market and the remeasurement of a portion of our net monetary assets denominated in bolivars at the parallel market exchange rate. See the section titled “Foreign Currency Translation – Venezuela Impacts” below for additional discussion. SG&A as a percentage of net sales declined 60 basis points due mainly to scale leverage from an increase in net sales.

Interest expense was $208 million for the quarter, down $79 million versus the prior year period primarily due to a reduction in debt outstanding and lower interest rates on floating rate debt. Other non-operating income/(expense),

 

- 17 -


net declined $34 million mainly behind lower interest and investment income and higher provisions for noncontrolling interests due to increased earnings in less than fully-owned subsidiaries. The effective tax rate on continuing operations increased 30 basis points to 28.0% primarily due to audit settlements in the prior year period.

Net earnings from continuing operations increased 2% to $3.1 billion for the quarter, in line with net sales growth. Operating margin declined 10 basis points as lower gross margin was largely offset by a reduction in SG&A as a percentage of net sales. The impact of lower interest expense was largely offset by lower other non-operating income/(expense), net and a higher effective tax rate. Diluted net earnings per share from continuing operations increased 5% to $1.02. Earnings per share growth exceeded net earnings growth due to the impact of share repurchase activity.

Net earnings from discontinued operations declined $280 million for the quarter due to the loss of contribution from the global pharmaceuticals business which was divested at the end of October 2009.

Net earnings declined 7% for the quarter to $3.1 billion behind a decrease in net earnings from discontinued operations, partially offset by an increase in net earnings from continuing operations. Diluted net earnings per share were down 4% to $1.02. The decline in earnings per share was less than the decline in net earnings due to the impact of share repurchases.

Foreign Currency Translation – Venezuela Impacts

Venezuela is a highly inflationary economy under U.S. GAAP. As a result, the U.S. dollar is the functional currency for our subsidiaries in Venezuela. Any currency remeasurement adjustments for non-dollar denominated monetary assets and liabilities held by these subsidiaries and other transactional foreign exchange gains and losses are reflected in earnings.

The Venezuelan government has introduced a number of currency controls for companies operating in Venezuela. Under these controls, there are two official exchange rates for imported goods. Those goods classified as essential, such as food, medicine and capital investments, have an exchange rate of 2.6 bolivars to the U.S. dollar, while payments for other non-essential goods have an exchange rate of 4.3. Many of our imported products fall into the essential classification and qualify for the 2.6 rate. However, our overall results in Venezuela are reflected in our Consolidated Financial Statements at the 4.3 rate expected to be applicable to dividend repatriations.

There are also exchange controls over securities transactions in the parallel market, which has historically been used to pay for imported goods and services that do not qualify for exchange in the official market. The Central Bank of Venezuela is the only legal intermediary through which parallel market transactions can be executed. The government controls the underlying parallel exchange rate which was approximately 5.3 at September 30, 2010. The notional amount of transactions that run through this parallel market mechanism is very restricted, which has eliminated our ability to access the parallel market to pay for imported goods and/or manage our local monetary asset balances.

As of September 30, 2010, we had net monetary assets denominated in local currency of approximately $490 million. Approximately $260 million of this balance has been remeasured using the parallel rate because we plan to use that amount of the net assets (largely cash) to satisfy U.S. dollar denominated liabilities that do not qualify for official rate dollars. The availability of the parallel market to settle these transactions is uncertain. The remaining net monetary asset balances are currently reflected within our Consolidated Financial Statements at the 4.3 official exchange rate. Depending on the future availability of U.S. dollars at the official rate, our local U.S. dollar needs and our overall repatriation plans, we have exposure for the differential between the official and parallel exchange rates on this portion of our local monetary assets.

 

- 18 -


 

Our ability to effectively manage sales and profit levels in Venezuela will be impacted by several factors, including the Company’s ability to mitigate the effect of the potential future devaluation, further actions of the Venezuelan government, economic conditions in Venezuela, such as inflation and consumer spending, the availability of raw materials, utilities and energy and the future state of exchange controls in Venezuela including the availability of U.S. dollars at the official foreign exchange rate.

BUSINESS SEGMENT DISCUSSION – Three Months Ended September 30, 2010

The following discussion provides a review of results by business segment. Analyses of the results for the three months ended September 30, 2010 are provided compared to the same three month period ended September 30, 2009. The primary financial measures used to evaluate segment performance are net sales and net earnings from continuing operations. The table below provides supplemental information on net sales and net earnings from continuing operations by business segment for the three months ended September 30, 2010 versus the comparable prior year period (amounts in millions):

 

     Three Months Ended September 30, 2010  
     Net Sales     % Change
Versus Year
Ago
    Earnings From
Continuing
Operations Before
Income Taxes
    % Change
Versus Year
Ago
    Net Earnings From
Continuing
Operations
    % Change
Versus Year
Ago
 

Beauty and Grooming GBU

            

Beauty

   $ 4,929        0   $ 1,081        5   $ 829        7

Grooming

     1,898        2     524        7     398        13

Health and Well-Being GBU

            

Health Care

     2,984        0     741        -11     495        -10

Snacks and Pet Care

     709        -6     77        -32     54        -27

Household Care GBU

            

Fabric Care and Home Care

     6,297        3     1,417        -6     937        -7

Baby Care and Family Care

     3,652        2     749        -15     470        -16

Corporate

     (347     N/A        (307     N/A        (102     N/A   
                                                

Total Company

     20,122        2     4,282        2     3,081        2
                                                

BEAUTY AND GROOMING GBU

Beauty

Beauty net sales were in line with the prior year period at $4.9 billion on unit volume growth of 4%. Organic sales grew 3%. Volume in developing regions increased double digits, while volume in developed regions declined low single digits. Mix reduced net sales by 2% behind disproportionate growth in developing regions, which have lower than segment average selling prices, and declines in the premium-priced categories of Prestige Products and Salon Professional. Unfavorable foreign exchange lowered net sales growth by 2%. Volume in Retail Hair Care increased mid-single digits due to double-digit growth in developing regions behind initiative activity and market growth. Volume in Female Beauty grew mid-single digits primarily behind double-digit growth of Olay, Safeguard and Venus. Volume in Salon Professional declined high single digits mainly due to the exit of non-strategic businesses. Volume in Prestige Products was down high single digits behind lower shipments in Western Europe and the divestiture of minor brands. Net earnings increased 7% to $829 million driven by higher operating margin due to higher gross margin and lower SG&A as a percentage of net sales. Gross margin expanded behind manufacturing cost savings. SG&A as a percentage of net sales declined due to lower overhead spending and reduced foreign currency exchange costs, partially offset by higher marketing spending.

Grooming

Grooming net sales increased 2% to $1.9 billion on a 5% increase in unit volume. Organic sales were up 6%.

 

- 19 -


 

Price increases, taken primarily across blades and razors, added 1% to net sales growth. Unfavorable foreign exchange reduced net sales growth by 4%. Volume grew double digits in developing regions and low single digits in developed regions. Male Grooming volume grew mid-single digits due to higher shipments of blades and razors, mainly in developing regions, and deodorants in North America and Latin America. Appliances volume increased high single digits behind increased shipments of beauty electronics, which includes shavers, epilators and hair care appliances. Global market share of the dry shave category increased over 2 points. Net earnings increased 13% to $398 million driven by higher net sales, increased operating margin and a lower tax rate. Operating margin increased behind higher gross margin and lower SG&A as a percentage of net sales. Gross margin increased due to improved product mix. SG&A as a percentage of net sales declined as lower foreign currency exchange costs and reduced overhead spending were only partially offset by higher marketing spending.

HEALTH AND WELL-BEING GBU

Health Care

Health Care net sales were in line with the prior year period at $3.0 billion on unit volume growth of 6%. Organic sales grew 4%. Pricing reduced net sales by 2%. Unfavorable foreign exchange reduced net sales by 4%. Volume increased double digits in developing regions and low single digits in developed regions. Oral Care volume was up high single digits behind the launch of Crest ProHealth Clinical and ProHealth For Me in North America, expansion of Oral-B toothpaste and success of ProHealth and Complete in Latin America and continued success of Crest ProHealth in Asia. Global market share of the oral care category was up half a point. Personal Health Care volume increased low single digits behind higher shipments of Vicks and PuR, mainly in CEEMEA, partially offset by a continued decline of Prilosec OTC in North America due to increased competitive activity. Feminine Care volume grew mid-single digits due to higher shipments of Naturella behind expansion into China and growth of Always mainly in CEEMEA. Global market share of the feminine care category was down half a point. Net earnings declined 10% to $495 million driven by lower operating margin. Operating margin contracted mainly due to a marketing-spending driven increase in SG&A as a percentage of net sales.

Snacks and Pet Care

Snacks and Pet Care net sales decreased 6% to $709 million on a 1% decline in unit volume. Organic sales were down 9%. Pricing reduced net sales by 2%. Product mix reduced net sales by 2% due to the disproportionate growth of Snacks, which have lower than segment average selling prices. Unfavorable foreign exchange lowered net sales by 1%. Organic volume, which excludes the impact of acquisitions and divestitures, declined 4%. Volume in Snacks increased high single digits mainly due to increased distribution in CEEMEA and Latin America and X-treme and multigrain initiatives in North America and Western Europe. Volume in Pet Care was down high single digits due mainly to supply constraints resulting from a restructuring of the supply chain and following the recall of select dry pet food products, partially offset by the impact of the Natura Pet Products acquisition in June 2010. Net earnings declined 27% to $54 million mainly due to lower net sales and incremental costs related to the pet food recall and supply chain restructuring efforts.

HOUSEHOLD CARE GBU

Fabric Care and Home Care

Fabric Care and Home Care net sales increased 3% to $6.3 billion on 10% unit volume growth. Organic sales were up 5% on 9% organic volume growth. Pricing lowered net sales by 2%. Negative product mix reduced net sales by 2% mainly due to disproportionate growth of mid-tier product lines and powdered laundry detergents, which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales by 3%. Volume in developing regions grew double digits, while volume in developed regions was up high single digits. Volume in Fabric Care increased high single digits mainly due to initiative activity and increased distribution in developing regions. Global market share of the fabric care category increased less than half a

 

- 20 -


point. Volume in Home Care was up double digits driven mainly by initiative launches, market growth and the Ambi Pur acquisition. Global market share of the home care category was up over one point. Volume in Batteries grew high single digits primarily due to price reductions executed through pack count increases in North America, higher demand from business customers and market growth and distribution expansion in developing regions. Global market share of the batteries category increased over half a point. Net earnings decreased 7% to $937 million as sales growth was more than offset by operating margin contraction. Operating margin declined due to lower gross margin and higher SG&A as a percentage of net sales. Gross margin contracted due mainly to lower pricing, unfavorable product mix and higher commodity costs. SG&A as a percentage of net sales increased behind higher marketing spending.

Baby Care and Family Care

Baby Care and Family Care net sales increased 2% to $3.7 billion on volume growth of 10%. Organic sales grew 5%. Pricing lowered net sales by 2%. Mix reduced net sales by 3% driven mainly by disproportionate growth of mid-tier product lines, larger package sizes and developing regions, all of which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales by 3%. Volume increased double digits in developing regions and high single digits in developed regions. Baby Care volume was up high single digits behind initiative activity, market size growth and distribution expansion, primarily in developing regions. Global market share of the baby care category increased over 1 point. Family Care volume grew double digits behind initiative activity, increased merchandising and additional distribution of Charmin in Latin America. U.S. all outlet share of the family care category increased half a point. Net earnings declined 16% to $470 million as sales growth was more than offset by lower operating margin. Operating margin declined mainly due to lower gross margin driven by higher commodity costs, lower pricing and unfavorable product mix. SG&A as a percentage of net sales declined due to lower foreign currency exchange costs and overhead spending, partially offset by higher marketing spending.

CORPORATE

Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; and certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate net sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and noncontrolling interest adjustments for subsidiaries where we do not have 100% ownership. Since certain unconsolidated entities and less than 100%-owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly-owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings in the segments, with eliminations for unconsolidated entities and noncontrolling interests in Corporate. In determining segment after-tax net earnings, we apply the statutory tax rates (with adjustments to arrive at the Company’s effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to noncontrolling interest.

Corporate net sales primarily reflect the adjustment to eliminate the sales of unconsolidated entities included in business segment results. Accordingly, Corporate net sales is generally a negative balance. Negative net sales in Corporate were down 18% primarily due to currency impacts on adjustments required to eliminate the sales of unconsolidated entities. Net expenses from continuing operations decreased $189 million to $102 million. The decline in net expenses was driven by prior year costs for remeasuring a portion of our local currency denominated net monetary assets in Venezuela and lower current period restructuring-type spending and interest expense.

 

- 21 -


 

FINANCIAL CONDITION

Operating Activities

We generated $2.5 billion of cash from operating activities in our first fiscal quarter. This represents a decline of 46% versus the prior year period primarily due to lower net earnings and higher levels of working capital. On a year-to-date basis, working capital consumed $1.3 billion of cash. Accounts receivable used $434 million of cash primarily due to increased sales later in the quarter, growth in categories, such as Respiratory, which have longer average payment terms and to support overall business growth. Inventory consumed $604 million of cash, mainly to support product initiatives and holiday-related shipments in some of our seasonal businesses. Accounts payable, accrued and other liabilities used $303 million of cash, primarily related to the payment of prior-year marketing accruals, which were unusually high due to several large initiative launches late in fiscal 2010.

Investing Activities

Our investing activities consumed cash of $928 million mainly to fund capital expenditures and acquisition activity. Acquisitions consumed $398 million due to the purchase of Ambi Pur, while proceeds from asset sales were minimal. Capital expenditures were $519 million or 2.6% of net sales. We expect capital expenditures of approximately 4% of net sales for the fiscal year. Cash used for investing activities increased $550 million versus the prior year period mainly due to net cash used for acquisitions and lower proceeds from divestitures.

Financing Activities

Our financing activities consumed net cash of $1.9 billion. We used $3.0 billion for treasury stock purchases and $1.4 billion for dividends and partially funded these cash outlays through the issuance of $2.4 billion of short-term debt. We expect to repurchase a total of $6 - $8 billion of treasury stock during fiscal 2011. Cash consumed by financing activities declined $902 million versus the prior year period due to increased levels of debt, partially offset by an increase in treasury stock purchases.

As of September 30, 2010, our current liabilities exceeded current assets by $7.1 billion. We have short- and long-term debt to fund discretionary items such as acquisitions and share repurchase programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements.

RECONCILIATION OF NON-GAAP MEASURES

Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion.

Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis.

 

- 22 -


 

The reconciliation of reported sales growth to organic sales for the July - September quarter:

 

Jul - Sep 2010

   Net
Sales
Growth
    Foreign
Exchange
Impact
    Acquisition/
Divestiture
Impact*
    Organic
Sales
Growth
 

Beauty

     0     2     1     3

Grooming

     2     4     0     6

Health Care

     0     4     0     4

Snacks and Pet Care

     -6     1     -4     -9

Fabric Care and Home Care

     3     3     -1     5

Baby Care and Family Care

     2     3     0     5
                                

Total P&G

     2     3     -1     4
                                

 

* Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales.

Free Cash Flow: Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation.

Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Company’s long-term target is to generate free cash at or above 90% of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions):

 

     Operating
Cash Flow
     Capital
Spending
    Free Cash Flow      Net Earnings      Free Cash Flow
Productivity
 

Jul - Sept ‘10

   $ 2,452       $ (519   $ 1,933       $ 3,081         63

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

There have been no material changes in the Company’s exposure to market risk since June 30, 2010. Additional information can be found in the section entitled Other Information, which appears on pages 48-49, and Note 5, Risk Management Activities and Fair Value Measurements, which appears on pages 59-62 of the Annual Report to Shareholders for the fiscal year ended June 30, 2010 which can be found by reference to Exhibit 13 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2010.

 

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures.

The Company’s Chairman of the Board, President and Chief Executive Officer, Robert A. McDonald, and the Company’s Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (“Exchange Act”)) as of the end of the period covered by this report. Messrs. McDonald and Moeller have concluded that the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. McDonald and Moeller, to allow their timely decisions regarding required disclosure.

 

- 23 -


 

Changes in Internal Control Over Financial Reporting.

There were no changes in our internal control over financial reporting that occurred during the Company’s fiscal quarter ended September 30, 2010 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

- 24 -


 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings.

The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters, labor and employment matters and taxes.

As previously reported, the Company is subject to a number of investigations into potential competition law violations in Europe. These investigations involve the European Commission, which is investigating potential competition law violations in a variety of countries across the European Union, as well as individual investigations by national authorities in Belgium, the Czech Republic, France, Germany, Greece, Italy, Romania, Spain, Switzerland and the United Kingdom. We believe that all of these matters involve a number of other consumer products companies and/or retail customers. Although non-monetary sanctions are not being sought in any of these matters, competition and antitrust law investigations often continue for several years and, if violations are found, can result in substantial fines. In other industries, fines have amounted to hundreds of millions of dollars.

The Company’s policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. In response to the actions of the European Commission and national authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company identified violations in certain European countries and appropriate actions were taken.

To date, authorities in the Czech Republic, France, Germany, Italy, Spain and Switzerland have issued separate complaints alleging that the Company, along with several other companies, engaged in violations of competition laws. The Company either has, or will have, the opportunity to respond to these complaints. The remaining matters discussed above are in various stages of the investigatory process.

The Company has taken, and will continue to take, reserves as appropriate. However, it is still too early for us to reasonably estimate the total amount of fines to which the Company will be subject as a result of these various competition law issues. Please refer to the Company’s Risk Factors in Item 1A of this Form 10-Q for additional information.

In December 2008, the Company became aware of an investigation by Italian authorities into an environmental accident at the site of a contractor which provides services to one or more of the Company’s European affiliates. The accident involved the explosion of certain pressurized cans and resulted in the death of one worker and serious injuries to another. Italian authorities have commenced a formal criminal proceeding regarding whether the Company’s local affiliate and certain of its employees complied with Italian laws related to the proper classification and disposal of their products. Should they find that these entities violated the law, the Italian authorities could levy fines in excess of $100 thousand against the Company’s European affiliate(s).

 

Item 1A. Risk Factors.

For a discussion of the Company’s risk factors, please refer to Part 1, “Item 1A. Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2010.

 

- 25 -


 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

ISSUER PURCHASES OF EQUITY SECURITIES

 

Period

   Total Number of
Shares Purchased (1)
     Average Price Paid
per Share (2)
     Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs (3)
     Approximate Dollar
Value of Shares That
May Yet Be  Purchased
Under our Share
Repurchase Program
($ in billions) (3) (4)
 

7/1/10 - 7/31/10

     11,470,548       $ 61.01         6,601,026         7.6   

8/1/10 - 8/31/10

     15,862,149       $ 60.22         15,861,838         6.6   

9/1/10 - 9/30/10

     27,354,884       $ 60.13         27,354,103         5.0   

 

(1) The total number of shares purchased was 54,687,581 for the quarter. This includes 1,347 shares acquired by the Company under various compensation and benefit plans and 4,869,267 shares acquired by the Profit Sharing Trust. All transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under these agreements, the Company prepays large financial institutions to deliver shares at future dates in exchange for a discount. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party and does not repurchase stock in connection with cashless exercise.
(2) Average price paid per share is calculated on a settlement basis and excludes commission.
(3) On August 3, 2010, the Company announced a share repurchase plan to acquire $6 to $8 billion of Company common stock during the fiscal year ending June 30, 2011 in open market and/or private transactions. This repurchase plan was authorized pursuant to a resolution issued by the Company’s Board of Directors and is expected to be financed by issuing a combination of long-term and short-term debt. Certain purchases were made prior to the announcement of the plan but are considered purchases against the plan.
(4) The dollar values listed in this column include commissions to be paid to brokers to execute the transactions.

 

- 26 -


 

Item 6. Exhibits

 

    3-1       Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 14, 2008) (Incorporated by reference to Exhibit (3-1) of the Company’s Form 10-Q for the quarter ended December 31, 2008).
    3-2       Regulations (as amended by the Board of Directors on April 18, 2010 pursuant to authority granted by shareholders at the annual meeting on October 13, 2009). (Incorporated by reference to Exhibit 3.ii of the Company’s Form 8-K filed on April 18, 2010).
  10-1       Summary of Performance Stock Program Summary (Incorporated by reference to Exhibit 99 of the Company’s Form 8-K filed on August 10, 2010). *
  11           Computation of Earnings per Share.
  12           Computation of Ratio of Earnings to Fixed Charges.
  31.1       Rule 13a-14(a)/15d-14(a) Certification – Chief Executive Officer
  31.2       Rule 13a-14(a)/15d-15(a) Certification – Chief Financial Officer
  32.1       Section 1350 Certifications – Chief Executive Officer
  32.2       Section 1350 Certifications – Chief Financial Officer
      101.INS  (1)   XBRL Instance Document
      101.SCH  (1)   XBRL Taxonomy Extension Schema Document
      101.CAL  (1)   XBRL Taxonomy Extension Calculation Linkbase Document
      101.DEF  (1)   XBRL Taxonomy Definition Linkbase Document
      101.LAB  (1)   XBRL Taxonomy Extension Label Linkbase Document
      101.PRE  (1)   XBRL Taxonomy Extension Presentation Linkbase Document

 

(1)

XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

* Compensatory plan or arrangement

 

- 27 -


 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    THE PROCTER & GAMBLE COMPANY
October 28, 2010    

  /s/    VALARIE L. SHEPPARD

Date       (Valarie L. Sheppard)
      Senior Vice President & Comptroller and Global
  Household Care Finance and Accounting

 

- 28 -


 

EXHIBIT INDEX

 

Exhibit

   
    3-1       Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 14, 2008) (Incorporated by reference to Exhibit (3-1) of the Company’s Form 10-Q for the quarter ended December 31, 2008).
    3-2       Regulations (as amended by the Board of Directors on April 18, 2010 pursuant to authority granted by shareholders at the annual meeting on October 13, 2009). (Incorporated by reference to Exhibit 3.ii of the Company’s Form 8-K filed on April 18, 2010).
  10-1       Summary of Performance Stock Program Summary (Incorporated by reference to Exhibit 99 of the Company’s Form 8-K filed on August 10, 2010).
  11           Computation of Earnings per Share.
  12           Computation of Ratio of Earnings to Fixed Charges.
  31.1       Rule 13a-14(a)/15d-14(a) Certification – Chief Executive Officer
  31.2       Rule 13a-14(a)/15d-15(a) Certification – Chief Financial Officer
  32.1       Section 1350 Certifications – Chief Executive Officer
  32.2       Section 1350 Certifications – Chief Financial Officer
      101.INS  (1)   XBRL Instance Document
      101.SCH  (1)   XBRL Taxonomy Extension Schema Document
      101.CAL  (1)   XBRL Taxonomy Extension Calculation Linkbase Document
      101.DEF  (1)   XBRL Taxonomy Definition Linkbase Document
      101.LAB  (1)   XBRL Taxonomy Extension Label Linkbase Document
      101.PRE  (1)   XBRL Taxonomy Extension Presentation Linkbase Document

 

(1)

XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.